Search Within

Heiko Schoder

  1. "Weinberg Fellows"
Formats
  1. Meeting Abstract (25)
  2. Journal Article (17)
  3. Research Letter (1)
Groups
  1. Department of Medicine (43)
  2. Molecular Imaging and Therapy Service (43)
  3. Radiology, Department of (43)
  4. Weinberg Fellows (43)
  5. Survivorship Research (32)
  6. Hematologic Malignancies, Division of (25)

More Groups

People
  1. Colette Owens (19)
  2. Alison Moskowitz (18)
  3. Andrew Zelenetz (18)
  4. Anita Kumar (18)
  5. Paul Hamlin (18)
  6. Ariela Noy (16)

More People

Years
  1. 2025 (1)
  2. 2024 (11)
  3. 2023 (7)
  4. 2022 (5)
  5. 2021 (10)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Blood (11)
  3. Journal of Nuclear Medicine (4)
  4. Hematological Oncology (3)
  5. Pancreas (2)
  6. Blood Advances (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (12)
  2. American Society of Hematology (12)
  3. Society of Nuclear Medicine (4)
  4. Wiley Blackwell (4)
  5. Elsevier Inc. (2)
  6. Lippincott Williams & Wilkins (2)

More Publishers

Results (43)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of nivolumab plus doxorubicin, vinblastine, dacarbazine as frontline therapy in older adults with Hodgkin lymphoma
    Journal Article

    Torka, P.; Feldman, T.; Savage, K. J.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Capadona, C.; Subzwari, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Pembrolizumab for front-line treatment of extranodal NK/T-cell lymphoma
    Meeting Abstract

    Moskowitz, A.; Advani, R. H.; Ganesan, N.; Chang, T.; Hancock, H.; Davey, T.; Miller, T.; Gibaldi, A.; Smith, M.; Assini, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Final response and survival results from a phase II trial of pembrolizumab and entinostat in relapsed/refractory Hodgkin lymphoma
    Meeting Abstract

    Stuver, R.; Vardhana, S. A.; Ganesan, N.; Boardman, A. P.; Caron, P.; Chang, T.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • An analysis of positron emission tomography maximum standard uptake value among patients with head and neck cancer receiving photon and proton radiation
    Journal Article

    Youssef, I.; Mohamed, N.; Kallini, D.; Zakeri, K.; Lin, H.; Han, D.; Qi, H.; Nosov, A.; Riaz, N.; Chen, L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Metabolic tumor volume response after bridging therapy determines chimeric antigen receptor T-cell outcomes in large B-cell lymphoma
    Journal Article

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G.; Fregonese, B.; Wills, B.; Bedmutha, A.; Alarcon Tomas, A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Noninvasive assessment of programmed-death ligand-1 (PD-L1) in esophagogastric (EG) cancer using (18)F-BMS-986229 PET
    Meeting Abstract

    Cytryn, S. L.; Pandit-Taskar, N.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Feder, L.; Philemond, S.; Lyashchenko, S. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Intra-treatment hypoxia directed major radiation de-escalation as definitive treatment for human papillomavirus-related oropharyngeal cancer
    Meeting Abstract

    Lee, N. Y.; Sherman, E. J.; Schòˆder, H.; Wray, R.; White, C.; Dunn, L.; Hung, T.; Pfister, D. G.; Ho, A. L.; McBride, S. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Induction chemotherapy effects on very advanced (T3/T4) human papillomavirus-related oropharyngeal cancer for participation in hypoxia-directed major deescalation (30 Gy) definitive treatment trial
    Meeting Abstract

    Sherman, E. J.; Riaz, N.; Dunn, L.; Schòˆder, H.; Wray, R.; Ganly, I.; Boyle, J.; Patel, S. G.; Givi, B.; Fetten, J. V.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Imaging with [(89)Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: A phase 1/2, first-in-human trial
    Journal Article

    Tendler, S.; Dunphy, M. P.; Agee, M.; O'Donoghue, J.; Aly, R. G.; Choudhury, N. J.; Kesner, A.; Kirov, A.; Mauguen, A.; Baine, M. K.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • (18)F-BMS-986229 PET to assess programmed-death ligand 1 status in gastroesophageal cancer
    Journal Article

    Cytryn, S. L.; Pandit-Taskar, N.; Lumish, M. A.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Antoine, A.; Loegel, D.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save